You are here

Article info

Article menu
Download PDFPDF
Commentary
What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?

Authors

  • Thales Paulo Batista Surgery, Federal University of Pernambuco, Recife, Pernambuco, Brazil Surgery/Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Pernambuco, Brazil PubMed articlesGoogle scholar articles
  • Heng-Cheng Hsu Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Thales Paulo Batista, Surgery, UFPE, Recife 50670-901, Pernambuco, Brazil; t.paulo{at}outlook.com

Citation

Batista TP, Hsu H
What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?
International Journal of Gynecologic Cancer 2021;31:642-643.

Publication history

  • Received November 20, 2020
  • Revision received December 2, 2020
  • Accepted December 4, 2020
  • First published December 24, 2020.
Online issue publication 
April 01, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.